We are leveraging newly discovered gene variants to address specific clinical problems such as risk prediction and distinguishing causes of disease from consequences.
Here are some of the questions we are working to answer:
Can we use gene variants to identify individuals at higher risk for heart attack?
Do triglyceride-rich lipoproteins cause heart attack?
Does HDL cholesterol causally protect from risk for heart attack?